Shire buys US drug firm Viro Pharma for $4.2bn

UK-listed drug company Shire has agreed to buy the US's Viro Pharma - a rare disease biopharmaceutical firm - for about $4.2bn (£2.6bn). Shire will pay $50 for each Viro Pharma share - a 27% premium on Friday's closing price. via Pocket http://www.bbc.co.uk/news/business-24895487#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa